Wednesday, June 10, 2026
🇺🇸 FDA

Drug profile · INN

molecular

molecular is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 17
News articles 0
Drug details — molecular
Class
—
Route
—
Patents
20
Programs
17
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

molecular is an FDA-listed pharmaceutical active ingredient.

Key facts

INN molecular

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. 2023/3720 UMBRELLA Phase 3 · George Institute for · patients with a positive status for molecular residual disea
  2. 19310 Phase 2 · Disc Medicine · Head and neck squamous cell carcinoma (HNSCC)
  3. AZD6738, Ceralasertib Phase 2 · AstraZeneca · Advanced Cancer Whose Tumours Contain Molecular Alterations
  4. CABL001E2201 Phase 2 · Novartis India · Chronic Myelogenous Leukemia in chronic phase (CML-CP), prev
  5. IRST100.59 Phase 2 · Istituto Gentili Italia · Solid tumors
  6. Low Molecular Weight Heparin (LMWH) Phase 2 · Cardiff Oncology · Cancer
  7. UC-0140/1711_UCBG3 Phase 2 · Ningbo Cancer Hospital · Triple-negative androgen receptor positive (molecular apocri
  8. Valemetostat Tosylate, Valemetostat Tosylate Phase 2 · George Institute for · Adult patients with histologically/cytologically confirmed p

Related patents

Browse patents

  1. US 12195620

    Controlled entrapment and release of molecular cargo

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12168718

    Thermogelling supramolecular sponge as self-healing and biocompatible hydrogel

    Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12076330

    Inhibition of lipofuscin aggregation by molecular tweezers

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12070444

    Modulation of molecular markers using S-equol

    Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11939379

    Antibody chemically induced dimerizer (AbCID) as molecular switches for regulating cellular therapies

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11891638

    Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11801229

    Molecular entrapment via homopolymer self-assembly

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11780904

    Method of producing recombinant high molecular weight vWF in cell culture

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11731986

    Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 2023203129

    ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES

    Expires Wed Jun 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11628229

    Method of synthesizing 18F radiolabeled biomolecular agents

    Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 2023040008

    ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES

    Expires Wed Feb 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11497788

    Supramolecular glycosaminoglycans

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11491231

    Peptide-oligonucleotide chimeras (POCs) as programmable biomolecular constructs for the assembly of morphologically-tunable soft materials

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11458212

    Molecular imaging of cancer cells in vivo

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11389544

    Formation of functionalized cancer targeting nanoparticles by supramolecular co-assembly

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11220486

    Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

    Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11124835

    Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11078471

    Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11066420

    Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is molecular?

molecular is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.